Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy

NCT02155595 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT02155595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02155595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy
Lead sponsor
Henry Ford Health System
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
August 31, 2018
Enrollment
738 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical femoral fractures, osteoporosis, prodromal bone deterioration